These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8516889)

  • 1. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor.
    Papadimitriou M; Vakianis P; Malliara M; Economidou D; Alexopoulos E; Belechri AM; Koukoudis P; Papadopoulou D; Syrganis C; Polymenidis Z
    Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 6. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients.
    Pallardó LM; García J; Sánchez J; Górriz JL; Orero E; Calabuig F
    Transplant Proc; 1992 Feb; 24(1):113-4. PubMed ID: 1539199
    [No Abstract]   [Full Text] [Related]  

  • 7. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.
    Transplant Proc; 1994 Oct; 26(5):2522-4. PubMed ID: 7940775
    [No Abstract]   [Full Text] [Related]  

  • 9. The therapeutic window of cyclosporine in Chinese recipients of renal transplantation.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1995 Feb; 27(1):850-1. PubMed ID: 7879203
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
    Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
    [No Abstract]   [Full Text] [Related]  

  • 13. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine.
    Isa WA; Robles JE; Rosell D; Aguera LG; de Castro F; Sanchez PL; Zudaire JJ; Errasti P; Berian JM
    Transplant Proc; 1992 Feb; 24(1):115-7. PubMed ID: 1539200
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine levels impact early rejection episodes.
    Granger DK; Amin NB; Sorenson AL; Gillingham KJ; Canafax DM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2513. PubMed ID: 7940771
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine A on chronic renal transplant rejection.
    Pabico RC; Yarger J; Byer B; Kremer M; McKenna BA; Cerilli GJ
    Transplant Proc; 1994 Oct; 26(5):2577-9. PubMed ID: 7940798
    [No Abstract]   [Full Text] [Related]  

  • 18. Live donor renal transplantation with low-dose triple immunosuppression.
    Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G
    Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow-up of 29 kidney transplant recipients having more than 20 years of functioning allografts.
    Fonseca JA; Ianhez LE; Azevedo LS; Sabbaga E
    Transplant Proc; 1992 Oct; 24(5):1863-4. PubMed ID: 1412886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.